A randomized phase I study of telisotuzumab adizutecan (ABBV-400, Temab-A) in combination with bevacizumab versus trifluridine–tipiracil with bevacizumab in patients with metastatic colorectal cancer ☆

Annals of Vascular Surgery · Elsevier

Аннотация

Publication date: Available online 24 October 2026 Source: Annals of Oncology Author(s): M. Cecchini, M. Cruz-Correa, S.-W. Han, K. Raghav, A. Landa-Magdalena, J.H. Strickler, A. Calvo, A. Hollebecque, T.E. Nakajima, G. Perl, V. Jain, Z. Hunter, E.M. Chan, M. Blaney, R. Li, A. Vasilopoulos, A. Parikh, M.R. Sharma

Читать у издателя →

Похожие статьи